GARY RAYMOND: Open Payments
NPI 1134171390 · SAN LUIS OBISPO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$722 in 7 payments from 5 companies in 2025. Trend: 2023 $683 · 2024 $876 · 2025 $722
Food & beverage: $722
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $225 |
| AstraZeneca Pharmaceuticals LP | 1 | $125 |
| Regeneron Healthcare Solutions, Inc. | 1 | $125 |
| Alkermes, Inc. | 1 | $124 |
| GlaxoSmithKline, LLC. | 1 | $123 |
Products named: BREZTRI, DUPIXENT, LYBALVI, AREXVY, Ozempic, Rybelsus.
Industry payments across CA — which companies pay providers there.
